Transdermal and Intradermal Drug Delivery Systems, 2017

Download Program

Advanced Design, Development, and Delivery of Skin-Mediated Therapies and Vaccines

The growing interest in alternative routes of drug administration has experts predicting that the market for transdermal and intradermal drug delivery systems will exceed $25 billion by 2018. The industry is on the threshold of bringing into commercial production a new generation of transformative TDD and IDD therapies and delivery systems. That is why you cannot afford to miss this two-day intensive conference. Pharma Ed brings together leading researchers in the field to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.

Featuring Representation From:

• Pfizer
• Merck
• Corium
• 3M
• MIT
• UCSB
• Queens University, Belfast
• Georgia Tech
• Texas Tech
• University of Mississippi
• University of Cincinnati
• Mercer University
• University of Maryland
• QPS
• Intertek
• Eurofins Lancaster Labs
• ISYN Consulting
• Zosano Pharma

With Comprehensive Coverage on:

• Improving Bioavailability Via Transdermal Administration
• Latest Advances in Microneedle Drug and Vaccine Delivery
• How to Move from Passive to Active Skin-Mediated Delivery Technologies for Drugs and Biologics
• Optimizing TDD & IDD for Efficacious Delivery and Patient Compliance
• Mechanisms of Dermal and Transdermal Absorption of Drugs
• Computational Modeling of Transdermal and Intradermal Delivery
• Resolving Regulatory Compliance Issues for TDD & IDD Systems
• IVPT and IVRT of Transdermal and Topical Products
• Exploring the Promise of Ionic Liquids for Transdermal Applications
• And much more!